Heena Sharma Blog

Yoga guru Ramdev's Patanjali Ayurved on Wednesday said there are no AYUSH Ministry restrictions on selling Coronil , a drug the company recently launched as a medicine for Covid-19 but is now calling it a product to manage the disease. The Union ministry confirmed that Patanjali can sell the product but not as a cure for Covid-19. AYUSH Ministry has only given permission to sell this particular formulation as immunity booster and not as a medicinal cure for Covid-19, it said. At a press conference in Haridwar, Ramdev claimed the ministry has said that Patanjali did an an appropriate job for Covid-19 management. Read More

Ramdev co-founded Patanjali Ayurved on Thursday signalled it had no intent to go slow in consumer goods, launching a slew of products amid sluggish annual sales. In 2017-18 (FY18), Patanjali’s top line grew only 13.6 per cent to Rs 120 billion versus an 88 per cent compounded annual growth rate it saw between FY12 and FY17. On Thursday, the firm forayed into dairy (including cow’s milk, curd, cheese, and butter), packaged water (called Divya Jal) and frozen vegetables (including peas, sweet corn, and potatoes), besides entering segments such as solar panels, and cattle feed. Patanjali also indicated that it was working on a plan of action in textiles and apparels, categories. “We are aiming to have a business of Rs 10 billion next financial year in dairy. This year, we will have a turnover of Rs 5 billion,” Ramdev said at a press meet at the Talkatora Stadium in the capital. ALSO READ: Why Patanjali Ayurved is faltering Patanjali already gets Rs 15 billion annually from cow’